In vivo visualization of pituitary dopaminergic receptors by iodine-123 methoxybenzamide (IBZM) correlates with sensitivity to dopamine agonists in two patients with macroprolactinomas

A. Scillitani, F. Dicembrino, P. Di Fazio, P. Paleani Vettori, V. D'Angelo, T. Scarabino, A. Liuzzi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'In vivo visualization of pituitary dopaminergic receptors by iodine-123 methoxybenzamide (IBZM) correlates with sensitivity to dopamine agonists in two patients with macroprolactinomas'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds